Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion | Zendy

Małgorzata Cichoń | Zendy; Magdalena MiziaSzubryt | Zendy; Magdalena OlszaneckaGlinianowicz | Zendy; Maria BożentowiczWikarek | Zendy; Aleksander Owczarek | Zendy; Rafał Michalik | Zendy; Katarzyna Mizia­Stec | Zendy

Open Access

Biomarkers of left atrial overload in obese and nonobese patients with atrial fibrillation qualified for electrical cardioversion

Author(s) -

Małgorzata Cichoń,

Magdalena MiziaSzubryt,

Magdalena OlszaneckaGlinianowicz,

Maria BożentowiczWikarek,

Aleksander Owczarek,

Rafał Michalik,

Katarzyna MiziaStec

Publication year - 2020

Publication title -

kardiologia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.527

H-Index - 34

eISSN - 1897-4279

pISSN - 0022-9032

DOI - 10.33963/kp.15673

Subject(s) - medicine , atrial fibrillation , copeptin , cardiology , cardioversion , pressure overload , electrical cardioversion , natriuretic peptide , heart failure , cardiac hypertrophy , vasopressin

Biomarkers of left atrial (LA) overload are considered factors affecting the efficacy of atrial fibrillation (AF) treatment. Increasing obesity rates contribute to a growing number of obese patients qualified for electrical cardioversion (CVE).Biomarkers of left atrial (LA) overload are considered as factors influencing efficacy of atrial fibrillation (AF) treatment. The increasing rate of obesity contributes to obese patients constituting a significant group of subjects qualified to electrical cardioversion (CVE).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research